3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Skin Neoplasms
2
Myelodysplastic Syndromes
2
Prostatic Neoplasms
1
Neoplasms
1
Myofibroma
1
Multiple Endocrine Neoplasia Type 1
1
Motor Activity
1
Limb-girdle muscular dystrophy, type 2C
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Intraocular Lymphoma
1
Inflammation
1
Hemorrhage
1
Eye Diseases
1
Diabetes Mellitus, Type 2
1
Diabetes Mellitus
1
Cytopenia
1
Corneal Endothelial Cell Loss
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Cataract
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Adenomyosis
1
Interventions
fludarabine phosphate
7
Peripheral Blood Stem Cell Transplantation
6
Cyclosporine
6
Busulfan
6
Mycophenolic Acid
5
Cyclophosphamide
5
Antilymphocyte Serum
5
Methotrexate
4
Filgrastim
4
Whole-Body Irradiation
3
Radiotherapy
3
Aprepitant
3
Therapeutics
2
Tacrolimus
2
Ondansetron
2
Methylprednisolone
2
Melphalan
2
Flow Cytometry
2
Dexamethasone
2
Cord Blood Stem Cell Transplantation
2
Calcium Dobesilate
2
thymoglobulin
1
fludarabine
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Voriconazole
1
Thiotepa
1
Sugars
1
Psychiatric Rehabilitation
1
Pravastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Leukemia, Myelomonocytic, Chronic
×
Ascorbic Acid
×
Clear all
NCT03682029
2024-04-17
EVITA
Rigshospitalet, Denmark
Phase NA
Unknown
109 enrolled